Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

LYELLYEL
5 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in LYELL IMMUNOPHARMA INC

CITADEL ADVISORS LLC holds 18,695 shares of LYEL (LYELL IMMUNOPHARMA INC), worth $262,665 as of 2026-Q2. The position was decreased (-95.1% shares).

Current Value

$262,665

Current Shares

18,695

Total Value Change

-$2.1M

Total Shares Change

-252,588

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
18,695
-95.1%
$262,6650.0%$14.05
0
2026-Q1
Increased
381,462
+17.5%
$7.7M0.0%$23.33
32
2025-Q4
Decreased
324,701
-4.4%
$10M0.0%$31.59
0
2025-Q3
Increased
339,491
+25.1%
$5.5M0.0%$14.97
33
2025-Q2
New
271,283
-
$2.4M0.0%$8.94
36

Other major holders of LYEL: VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used